SGMO Retrace

Sangamo Therapeutics, Inc.NASDAQ

Beschreibung

⋅ 2. Jul. 2019 02:19

SGMO will retrace slightly before its FDA approval, still trading above 100 EMA, MFI/RSI cooling off.